Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-20

Clinical Trial Update: Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDS [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy of fenugreek seed and Lespedeza cuneata for hypogonadism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenugreek seed (Trigonella foenum-graecum seed)
  • Lespedeza cuneata (Lespedeza cuneata)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Hypogonadism | Phase 4 | Status: COMPLETED